5-methoxy-2,3-bis(methylthio)cyclohexa-2,5-diene-1,4-dione (Blue benzoquinone)

The blue benzoquinone is a novel antimicrobial agent isolated from the venom of the scorpion Diplocentrus melici. It demonstrates exceptional potency against both drug-sensitive and multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, with a minimum inhibitory concentration (MIC) of approximately 4 µg/mL. Biologically, the compound acts by inducing massive oxidative stress through the production of reactive oxygen species and the depletion of the protective thiol glutathione. This oxidative damage is accompanied by severe disruption of the mycobacterial cell wall, leading to rapid bactericidal action. In vivo studies in mouse models of progressive pulmonary tuberculosis have shown that intratracheal administration of the blue benzoquinone significantly reduces lung bacillary load and pneumonia without causing adverse effects on healthy lung tissue. Its unique mechanism, which circumvents traditional resistance pathways, makes it a promising lead for the development of new antitubercular therapies.

Other names

Blue scorpion venom benzoquinoneDiplocentrus melici blue compound3,5-bis(methylthio)-2-methoxy-1,4-benzoquinone

The blue benzoquinone exerts its bactericidal effect through a multifaceted mechanism that includes the generation of high levels of reactive oxygen species (ROS) via redox cycling, leading to oxidative DNA damage and protein oxidation. It also causes significant structural damage to the mycobacterial cell wall, resulting in cytoplasmic extraction and cell death, a process that mimics the effects of isoniazid. Furthermore, it depletes intracellular glutathione through direct oxidation, compromising the bacteria's antioxidant defenses.